Adaptilens fetches $1.6m seed

Boston-based Adaptilens, a developer of an adjustable intraocular lens, has secured $1.6 million in seed funding.

12 November 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles